focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 157.50
Bid: 155.00
Ask: 160.00
Change: 17.50 (12.50%)
Spread: 5.00 (3.226%)
Open: 141.50
High: 157.50
Low: 141.50
Prev. Close: 140.00
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding and Total Voting Rights

11 Oct 2013 07:00

RNS Number : 2495Q
Revolymer PLC
11 October 2013
 



11 October 2013

Revolymer plc

("Revolymer" or "the Company")

Director/PDMR Shareholding and Total Voting Rights

 

Revolymer received notice on 10 October 2013 that the Non-executive Chairman of the Company, Mr Jack Keenan, had exercised share options ("Options") over 324,480 new ordinary shares of 1p each (the "New Ordinary Shares"). The Options comprise 162,030 options at an exercise price of 25.00 pence each, 96,030 options at an exercise price of 26.17 pence each and 66,420 options at an exercise price of nil. The Company has a block listing facility in place over this scheme and is drawing down 324,480 block listing shares to cover the exercise. The block listing shares rank pari passu in all respects with the existing issued ordinary shares of 1p each ("Ordinary Shares") in the share capital of Revolymer. At completion of the exercise Mr Keenan holds 781,750 Ordinary Shares in the Company, representing 1.4 per cent. of the shares in issue. Mr Keenan has no further share options over Ordinary Shares.

 

As of 11 October 2013, the Company's issued share capital therefore consists of 54,166,180 Ordinary Shares, each with voting rights attached (one per ordinary share) the Company does not hold any Ordinary Shares in treasury.

 

Therefore the total number of Ordinary Shares in the Company with voting rights is 54,166,180.

 

The above figure of 54,166,180 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or changes to their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

Ends

 

For further information please contact:

 

Revolymer plc

+44 (0) 1244 283 500

Roger Pettman

Rob Cridland

 

Panmure Gordon (UK) Limited

+44 (0) 20 7886 2500

Callum Stewart / Adam James (Corporate Finance)

Adam Pollock / Charles Leigh-Pemberton (Corporate Broking)

Citigate Dewe Rogerson

+44 (0)20 7638 9571

David Dible / Ginny Pulbrook/Malcolm Robertson

 

 

 

About Revolymer

Revolymer is a technology company that designs, develops and formulates novel polymers to improve the performance of existing consumer products within the FMCG and other industrial markets. Revolymer's strategy is to generate significant and growing revenue streams by licensing its unique and proprietary technologies to manufacturers and marketers within these global high value markets. Current applications for the Group's technologies are in the household products, personal care and coatings & adhesives markets (together "Consumer Specialties") and the medicated chewing gum and confectionery chewing gum (together "Gum") markets.

www.revolymer.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFIFLSFDSELS
Date   Source Headline
27th Jul 20217:00 amRNSTrading Statement
19th Jul 202111:05 amRNSSecond Price Monitoring Extn
19th Jul 202111:00 amRNSPrice Monitoring Extension
19th Jul 20217:00 amRNSRemoval of US Securities Law Restrictions
24th Jun 20213:18 pmRNSResult of Annual General Meeting
18th Jun 20217:00 amRNSChanges to AGM Arrangements, Investor Presentation
9th Jun 20219:00 amRNSPrice Monitoring Extension
9th Jun 20217:00 amRNSCompleted New Funding with Institutional Investors
8th Jun 20212:05 pmRNSSecond Price Monitoring Extn
8th Jun 20212:00 pmRNSPrice Monitoring Extension
8th Jun 202111:05 amRNSSecond Price Monitoring Extn
8th Jun 202111:00 amRNSPrice Monitoring Extension
8th Jun 20217:00 amRNSTrading Update
27th May 20217:00 amRNSNotice of AGM
20th May 20214:41 pmRNSSecond Price Monitoring Extn
20th May 20214:35 pmRNSPrice Monitoring Extension
20th May 20217:00 amRNSItaconix receives the LSE's Green Economy Mark
9th Apr 20211:07 pmRNSIssue of Shares, Director/PDMR Dealings
30th Mar 20217:00 amRNSFull Year Results Ended 31 December 2020
24th Mar 202111:06 amRNSSecond Price Monitoring Extn
24th Mar 202111:00 amRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSNotice of Final Results and Investor Presentation
23rd Mar 20212:06 pmRNSSecond Price Monitoring Extn
23rd Mar 20212:00 pmRNSPrice Monitoring Extension
23rd Mar 202111:05 amRNSSecond Price Monitoring Extn
23rd Mar 202111:00 amRNSPrice Monitoring Extension
28th Jan 20212:06 pmRNSSecond Price Monitoring Extn
28th Jan 20212:01 pmRNSPrice Monitoring Extension
27th Jan 202111:06 amRNSSecond Price Monitoring Extn
27th Jan 202111:00 amRNSPrice Monitoring Extension
26th Jan 202111:05 amRNSSecond Price Monitoring Extn
26th Jan 202111:00 amRNSPrice Monitoring Extension
26th Jan 20217:00 amRNSTrading Update for the year ended 31 December 2020
21st Jan 202111:05 amRNSSecond Price Monitoring Extn
21st Jan 202111:01 amRNSPrice Monitoring Extension
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn
18th Jan 20212:01 pmRNSPrice Monitoring Extension
14th Jan 20214:41 pmRNSSecond Price Monitoring Extn
14th Jan 20214:35 pmRNSPrice Monitoring Extension
14th Jan 20212:06 pmRNSSecond Price Monitoring Extn
14th Jan 20212:01 pmRNSPrice Monitoring Extension
14th Jan 20217:00 amRNSAppointment of new Vice President, Operations
8th Jan 202111:06 amRNSSecond Price Monitoring Extn
8th Jan 202111:00 amRNSPrice Monitoring Extension
30th Dec 202011:05 amRNSSecond Price Monitoring Extn
30th Dec 202011:00 amRNSPrice Monitoring Extension
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
3rd Nov 20207:00 amRNSAppointment of New Marketing and Sales Executive
28th Oct 20207:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.